- Home
- ETON vs AGL Comparison
ETON vs AGL Comparison
Compare ETON & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- AGL
- Stock Information
- Founded
- ETON 2017
- AGL 2016
- Country
- ETON United States
- AGL United States
- Employees
- ETON N/A
- AGL N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- AGL Managed Health Care
- Sector
- ETON Health Care
- AGL Health Care
- Exchange
- ETON Nasdaq
- AGL Nasdaq
- Market Cap
- ETON 388.3M
- AGL 443.4M
- IPO Year
- ETON 2018
- AGL 2021
- Fundamental
- Price
- ETON $21.45
- AGL $1.07
- Analyst Decision
- ETON Strong Buy
- AGL Hold
- Analyst Count
- ETON 3
- AGL 20
- Target Price
- ETON $29.67
- AGL $2.75
- AVG Volume (30 Days)
- ETON 343.9K
- AGL 6.2M
- Earning Date
- ETON 11-11-2025
- AGL 11-04-2025
- Dividend Yield
- ETON N/A
- AGL N/A
- EPS Growth
- ETON N/A
- AGL N/A
- EPS
- ETON N/A
- AGL N/A
- Revenue
- ETON $58,181,000.00
- AGL $5,901,182,000.00
- Revenue This Year
- ETON $105.25
- AGL N/A
- Revenue Next Year
- ETON $40.84
- AGL $6.21
- P/E Ratio
- ETON N/A
- AGL N/A
- Revenue Growth
- ETON 85.40
- AGL 11.76
- 52 Week Low
- ETON $6.37
- AGL $0.71
- 52 Week High
- ETON $23.00
- AGL $6.08
- Technical
- Relative Strength Index (RSI)
- ETON 66.33
- AGL 40.92
- Support Level
- ETON $19.48
- AGL $1.11
- Resistance Level
- ETON $23.00
- AGL $1.18
- Average True Range (ATR)
- ETON 1.15
- AGL 0.07
- MACD
- ETON 0.04
- AGL 0.01
- Stochastic Oscillator
- ETON 70.50
- AGL 25.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.